Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

594 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical Exercise.
Lestuzzi C, Stolfo D, De Paoli A, Banzato A, Buonadonna A, Bidoli E, Tartuferi L, Viel E, De Angelis G, Lonardi S, Innocente R, Berretta M, Bergamo F, Guglielmi A, Sinagra G, Herrmann J. Lestuzzi C, et al. Among authors: lonardi s. Oncologist. 2022 Mar 4;27(2):e158-e167. doi: 10.1093/oncolo/oyab035. Oncologist. 2022. PMID: 35641220 Free PMC article.
Chemotherapy for operable and advanced colorectal cancer.
Aschele C, Bergamo F, Lonardi S. Aschele C, et al. Among authors: lonardi s. Cancer Treat Rev. 2009 Oct;35(6):509-16. doi: 10.1016/j.ctrv.2009.04.003. Epub 2009 May 29. Cancer Treat Rev. 2009. PMID: 19481872 Review.
Hepatoid adenocarcinoma of the colon: what should we target?
Cappetta A, Bergamo F, Mescoli C, Lonardi S, Rugge M, Zagonel V. Cappetta A, et al. Among authors: lonardi s. Pathol Oncol Res. 2012 Jan;18(1):93-6. doi: 10.1007/s12253-011-9424-5. Epub 2011 Jun 12. Pathol Oncol Res. 2012. PMID: 21667305 Free article.
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines.
Toffoli G, Giodini L, Buonadonna A, Berretta M, De Paoli A, Scalone S, Miolo G, Mini E, Nobili S, Lonardi S, Pella N, Lo Re G, Montico M, Roncato R, Dreussi E, Gagno S, Cecchin E. Toffoli G, et al. Among authors: lonardi s. Int J Cancer. 2015 Dec 15;137(12):2971-80. doi: 10.1002/ijc.29654. Epub 2015 Jul 14. Int J Cancer. 2015. PMID: 26099996 Free article.
Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New Hope.
Pietrantonio F, Cremolini C, Aprile G, Lonardi S, Orlandi A, Mennitto A, Berenato R, Antoniotti C, Casagrande M, Marsico V, Marmorino F, Cardellino GG, Bergamo F, Tomasello G, Formica V, Longarini R, Giommoni E, Caporale M, Di Bartolomeo M, Loupakis F, de Braud F. Pietrantonio F, et al. Among authors: lonardi s. Oncologist. 2015 Nov;20(11):1261-5. doi: 10.1634/theoncologist.2015-0171. Epub 2015 Oct 7. Oncologist. 2015. PMID: 26446234 Free PMC article.
HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment.
Garziera M, Bidoli E, Cecchin E, Mini E, Nobili S, Lonardi S, Buonadonna A, Errante D, Pella N, D'Andrea M, De Marchi F, De Paoli A, Zanusso C, De Mattia E, Tassi R, Toffoli G. Garziera M, et al. Among authors: lonardi s. PLoS One. 2015 Dec 3;10(12):e0144000. doi: 10.1371/journal.pone.0144000. eCollection 2015. PLoS One. 2015. PMID: 26633805 Free PMC article.
Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
Dreussi E, Pucciarelli S, De Paoli A, Polesel J, Canzonieri V, Agostini M, Friso ML, Belluco C, Buonadonna A, Lonardi S, Zanusso C, De Mattia E, Toffoli G, Cecchin E. Dreussi E, et al. Among authors: lonardi s. Oncotarget. 2016 Apr 12;7(15):19781-93. doi: 10.18632/oncotarget.7757. Oncotarget. 2016. PMID: 26934318 Free PMC article.
594 results